Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant

Clinical trial NCT02846376 · TERMINATED

Trial details

NCT number: NCT02846376
Sponsor: Hackensack Meridian Health
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia and Myelodysplastic Syndrome

Start date: 2019-03-08
Primary completion: 2023-12-21
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.